JMI LABS IS NOW PART OF LEARN MORE

Ceftolozane-tazobactam activity against Pseudomonas aeruginosa clinical isolates from US hospitals: Report from an antimicrobial surveillance program (PACTS, 2012-2015). by Shortridge D, Castanheira M, Pfaller MA and Flamm RK published in Antimicrob. Agents Chemother. 2017; 61: e00465

View publication